Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials
Clinical cancer research, 2017-10, Vol.23 (19), p.5679-5686 [Peer Reviewed Journal]2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Oct 1, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-0944 ;PMID: 28972083
Full text available